ProMIS Neurosciences Inc. announced a one-for-twenty-five reverse stock split of the Company's common shares.
The reverse stock split will take effect on November 28, 2025.
This action will reduce the number of outstanding Common Shares from approximately 53,811,110 million shares to approximately 2,152,444 million shares.
Reverse Stock Split
ProMIS Neurosciences is implementing a one-for-twenty-five reverse stock split of its common shares.
Compliance with Nasdaq Listing
The reverse stock split aims to increase the market price for ProMIS Common Shares to comply with the Bid Price Rule on The Nasdaq Capital Market.
Reduction in Outstanding Shares
The reverse stock split will significantly reduce the number of outstanding Common Shares.
- The reverse stock split will consolidate shares, potentially increasing the per-share price and liquidity of ProMIS Neurosciences Inc.
- Stockholders do not need to take action as the reverse stock split will be reflected in their accounts after November 28, 2025.
ProMIS's decision to implement a reverse stock split reflects its commitment to meeting listing requirements and enhancing shareholder value.